BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.560
+0.050 (3.31%)
Oct 14, 2025, 3:14 PM EDT - Market open
BioCardia Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioCardia stock has a target of 25, which predicts a 1,502.56% increase from the current stock price of 1.56.
Price Target: $25 (+1,502.56%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for BioCardia is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,502.56% | Sep 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,502.56% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,502.56% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,502.56% | Oct 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,502.56% | Aug 21, 2024 |
Financial Forecast
Revenue This Year
51.00K
from 58.00K
Decreased by -12.07%
Revenue Next Year
51.00K
from 51.00K
EPS This Year
-1.07
from -2.90
EPS Next Year
-1.02
from -1.07
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 105,000 | 105,000 | ||
| Avg | 51,000 | 51,000 | ||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 81.0% | 105.9% | ||
| Avg | -12.1% | - | ||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.10 | -1.05 | ||
| Avg | -1.07 | -1.02 | ||
| Low | -1.03 | -0.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.